Health-related quality of life with adjuvant immune checkpoint inhibition in renal cell carcinoma: A qualitative study of UK participants in the phase III RAMPART trial.
Merrick S et al. · 2026
NCBI PubMed Central · Papers · License: Open Access · 2026